LZTS2 anticorps
Aperçu rapide pour LZTS2 anticorps (ABIN7115825)
Antigène
Voir toutes LZTS2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- LZTS2 antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- leucine zipper, putative tumor suppressor 2
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
Autre désignation
- LZTS2
-
Sujet
-
Synonyms: Leucine zipper putative tumor suppressor 2 (hLZTS2)|Protein LAPSER1|LZTS2|KIAA1813|LAPSER1
Background: Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.
-
Poids moléculaire
- 70-80 kDa
-
ID gène
- 84445
-
UniProt
- Q9BRK4
Antigène
-